March 27, 2017 12:47 PM ET

Biotechnology

Company Overview of Kala Pharmaceuticals, Inc.

Company Overview

Kala Pharmaceuticals, Inc. develops ophthalmic treatments based on its mucosal penetrating product (MPP) platform. It offers transformative therapies for severe ophthalmic diseases. The company’s MPP technology platform allows therapeutic agents to pass through the mucus layer of the ocular surface, facilitating penetration into deeper tissues of the eye, including the aqueous humor and retina. Its solutions are used in treating severe ophthalmic diseases, including ocular inflammation and wet age-related macular degeneration. Kala Pharmaceuticals, Inc. was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in July 2010. The company was incorporated in 200...

100 Beaver Street

Suite 201

Waltham, MA 02453

United States

Founded in 2009

Phone:

781-996-5252

Fax:

781-642-0399

Key Executives for Kala Pharmaceuticals, Inc.

Executive Chairman and Chief Executive Officer
Age: 50
Founder, Chairman of the Scientific Advisory Board and Director
Chief Medical Officer
Executive Vice President of Research
General Counsel
Compensation as of Fiscal Year 2016.

Kala Pharmaceuticals, Inc. Key Developments

Kala Pharmaceuticals, Inc. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-11-2017 04:00 PM

Kala Pharmaceuticals, Inc. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-11-2017 04:00 PM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Mark T. Iwicki, Executive Chairman and Chief Executive Officer.

Kala Pharmaceuticals, Inc. Presents at Wedbush PacGrow Healthcare Conference 2016, Aug-17-2016 10:55 AM

Kala Pharmaceuticals, Inc. Presents at Wedbush PacGrow Healthcare Conference 2016, Aug-17-2016 10:55 AM. Venue: Le Parker Meridien, New York, New York, United States.

Kala Pharmaceuticals, Inc. Announces Board Appointments

Kala Pharmaceuticals, Inc. announced that Gregory Grunberg, Managing Director at Longitude Capital, and Chen Yu, Managing Partner at Vivo Capital, joined as new Board members. Rajeev Shah, Managing Director and Portfolio Manager at RA Capital Management, joined the company's Board of Directors last year. Jonathan Silverstein, Partner and a Co-Head of Global Private Equity at OrbiMed, will hold a Board observer seat.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 6, 2016
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kala Pharmaceuticals, Inc., please visit www.kalarx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.